OTCMKTS:CPHRF - Cipher Pharmaceuticals Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.95
  • Forecasted Upside: -40.25 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.59
+0.30 (1.20%)

This chart shows the closing price for CPHRF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cipher Pharmaceuticals Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CPHRF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CPHRF

Analyst Price Target is $0.95
▼ -40.25% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Cipher Pharmaceuticals in the last 3 months. The average price target is $0.95, with a high forecast of $0.95 and a low forecast of $0.95. The average price target represents a -40.25% upside from the last price of $1.59.

This chart shows the closing price for CPHRF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Cipher Pharmaceuticals. This rating has held steady since September 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/22/2021Stifel NicolausBoost Price TargetHold$0.85 ➝ $0.95
1/19/2021Stifel NicolausLower Price TargetHold$1.00 ➝ $0.85
10/6/2020Bloom BurtonReiterated RatingBuy$2.00
8/27/2020Echelon Wealth PartnersReiterated RatingBuy$3.00
8/16/2020Bloom BurtonReiterated RatingBuy$2.00
5/11/2020Stifel NicolausReiterated RatingHold
1/22/2020Echelon Wealth PartnersReiterated RatingBuy$4.00
11/12/2019Echelon Wealth PartnersReiterated RatingBuy$4.00
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.98 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Cipher Pharmaceuticals

Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Oakville, Canada.
Read More

Today's Range

Now: $1.59
Low: $1.59
High: $1.59

50 Day Range

MA: $1.94
Low: $1.59
High: $2.22

52 Week Range

Now: $1.59
Low: $0.60
High: $2.25

Volume

30 shs

Average Volume

11,185 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Cipher Pharmaceuticals?

The following Wall Street sell-side analysts have issued reports on Cipher Pharmaceuticals in the last year: Stifel Nicolaus.
View the latest analyst ratings for CPHRF.

What is the current price target for Cipher Pharmaceuticals?

1 Wall Street analysts have set twelve-month price targets for Cipher Pharmaceuticals in the last year. Their average twelve-month price target is $0.95, suggesting a possible downside of 40.3%. Stifel Nicolaus has the highest price target set, predicting CPHRF will reach $0.95 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $0.95 for Cipher Pharmaceuticals in the next year.
View the latest price targets for CPHRF.

What is the current consensus analyst rating for Cipher Pharmaceuticals?

Cipher Pharmaceuticals currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CPHRF, but not buy more shares or sell existing shares.
View the latest ratings for CPHRF.

What other companies compete with Cipher Pharmaceuticals?

How do I contact Cipher Pharmaceuticals' investor relations team?

Cipher Pharmaceuticals' physical mailing address is 2345 Argentia Rd Suite 100A, MISSISSAUGA, ON L5N 8K4, Canada. The company's listed phone number is (905) 602-5840. The official website for Cipher Pharmaceuticals is www.cipherpharma.com.